High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.4M
$1,421,022
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BBIO |
BridgeBio Pharma, Inc.
|
Director
Other
|
2026-02-17 | $167,500 | M | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 Sell
|
2026-02-17 | $141,250 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -24.3%
|
2026-02-17 | $362,219 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -22.2%
|
2026-02-17 | $251,088 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -17.6%
|
2025-11-17 | $251,809 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -34.9%
|
2025-11-17 | $414,656 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
Director
Other
|
2025-11-17 | $167,500 | M | Form 4 |